- POSITIVE
Annual Revenue Studio LSD Mar-2025 Annual Revenue is Rs 105 Cr which is growth of 2.5% YoY.
- POSITIVE
Annual Net Profit Studio LSD Mar-2025 Annual Net Profit is Rs 12 Cr which is growth of 8.0% YoY.
8.50-0.20(-2.30%)
8,000
NSE Volume
NSE 14 Oct, 2026 2:10 PM (IST)
Studio LSD quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Studio LSD competitor comparison and performance snapshot within industry
Studio LSD annual results: revenue, profit, P&L, and margins as of Mar 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|---|
93% | 105 | 102.5 | 46.7 | 14.6 | 6 | ||
Operating Exp. Ann. | 87% | 89 | 87.6 | 42.9 | 13.6 | 7.1 | |
Operating Profit Ann. | 149.3% | 15.5 | 14.9 | 3.8 | 1 | -1.5 | |
OPM Ann. % | 28.8% | 14.77% | 14.51% | 8.19% | 6.92% | -25.27% | |
86.7% | 89.2 | 87.8 | 43.1 | 13.7 | 7.3 | ||
EBITDA Ann. | 152% | 16 | 14.9 | 3.9 | 1 | -1.1 | |
EBITDA Ann. margin % | 30.1% | 15.28% | 14.53% | 8.26% | 6.94% | -18.77% | |
Interest Ann. | 0% | 0.1 | 0.2 | 0.1 | 0.1 | ||
Depr. | - | 0.3 | 0.2 | 0 | 0 | 0.1 | |
PBT Ann. | 159.9% | 15.8 | 14.7 | 3.6 | 0.9 | -1.3 | |
Tax Ann. | - | 4.1 | 3.9 | 0.8 | -0 | -0 | |
135.1% | 11.7 | 10.8 | 2.8 | 0.9 | -1.2 | ||
Net Profit Ann. | 135.1% | 11.7 | 10.8 | 2.8 | 0.9 | -1.2 | |
NPM Ann. % | 21.5% | 11.16% | 10.54% | 5.98% | 6.22% | -22.07% | |
EPS Adj. latest Ann. | 125.7% | 2.3 | 2.1 | 0.5 | 0.2 | -0.2 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
2.4%
2Y CAGR
49.9%
3Y CAGR
93%
Net Profit Ann.
1Y CHG
8.3%
2Y CAGR
104.4%
3Y CAGR
135.1%
Operating Exp. Ann.
1Y CHG
1.6%
2Y CAGR
44%
3Y CAGR
87%
Studio LSD balance sheet as of Mar 2025: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Studio LSD Mar-2025 Total Shareholders Fund is Rs 28 Cr which is growth of 74.6% YoY.
- POSITIVE
Total Assets Studio LSD Mar-2025 Total Assets is Rs 47 Cr which is growth of 28.2% YoY.
| Indicator | Graph | CAGR 3 Yrs | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|---|
132.1% | 27.5 | 15.8 | 5 | 2.2 | 1.3 | ||
Minority Interest Liability Ann. | - | - | - | - | - | - | |
- | 0.1 | ||||||
111.8% | 19 | 20.6 | 13.2 | 2 | 4.1 | ||
Total Capital Plus Liabilities Ann. | 125% | 46.7 | 36.4 | 18.2 | 4.1 | 5.3 | |
71% | 0.5 | 0.8 | 0.3 | 0.1 | 0.1 | ||
86.9% | 11.1 | 3.5 | 1.5 | 1.7 | 0.6 | ||
142.4% | 35.6 | 32.9 | 16.6 | 2.5 | 4.8 | ||
Total Assets Ann. | 125% | 46.7 | 36.4 | 18.2 | 4.1 | 5.3 | |
Contingent Liabilities plus Commitments Ann. | - | 1.2 | 1.2 | 0.9 | |||
Bonus Equity Share Capital Ann. | - | 8.2 | |||||
Non Current Investments Unquoted Book Value Ann. | - | 0 | 0 | 0 | 0 | ||
Current Investments Unquoted Book Value Ann. | - |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
28.3%
2Y CAGR
60.2%
3Y CAGR
125%
Total Current Liabilities Ann.
1Y CHG
-7.8%
2Y CAGR
20%
3Y CAGR
111.8%
Total ShareHolders Funds Ann.
1Y CHG
74.1%
2Y CAGR
134.5%
3Y CAGR
132.1%
Studio LSD ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Book Value Per Share Studio LSD Mar-2025 Book Value Per Share is 7 Rs which is growth of -100.0% YoY.
- POSITIVE
ROE Studio LSD Mar-2025 ROE is 42% which is growth of 26.2% YoY.
| Indicator | Graph | CAGR 3 Yrs | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|---|
BVSH Ann. | -85.4% | 6.7 | 15,769.1 | 4,961.5 | 2,166.5 | 1,256.8 | |
RoA Ann. % | 4.4% | 25.00% | 29.69% | 15.39% | 21.96% | -23.37% | |
ROE Ann. % | 0.3% | 42.37% | 68.53% | 56.33% | 41.99% | -98.79% | |
ROCE Ann. % | 7.9% | 57.02% | 93.29% | 76.89% | 45.35% | -93.58% | |
Total Debt to Total Equity Ann. | 0 | 0.4 | 0.7 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
-38.2%
2Y CAGR
-13.3%
3Y CAGR
0.3%
RoA Ann. %
1Y CHG
-15.8%
2Y CAGR
27.5%
3Y CAGR
4.4%
Current Ratio Ann.
1Y CHG
18.7%
2Y CAGR
20.9%
3Y CAGR
16.6%
Studio LSD cash flow: net, operating, investing, and financing flows as of Mar 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Cash From Operating Activity Studio LSD Mar-2025 Cash From Operating Activity is Rs 6 Cr which is growth of -40.1% YoY.
- NEGATIVE
Net Cash Flow Studio LSD Mar-2025 Net Cash Flow is Rs -3 Cr which is growth of -147.5% YoY.
| Indicator | Graph | CAGR 3 Yrs | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|---|
168.4% | 5.8 | 9.6 | 1.4 | 0.3 | |||
Cash from Investing Act. Ann. | - | -9.2 | -2.4 | -0.2 | -0 | ||
Cash from Financing Act. Ann. | - | -0.1 | -0.8 | -0.2 | |||
- | -3.4 | 7.2 | 0.3 | 0 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
-39.6%
2Y CAGR
103.5%
3Y CAGR
168.4%